These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6997988)

  • 1. Complement (C3) conversion by rat intestinal glycoprotein and its degradation products.
    Winsnes R
    Scand J Immunol; 1980; 12(1):67-76. PubMed ID: 6997988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of calcium and factor D depletion on C3 conversion by rat intestinal glycoprotein.
    Winsnes R
    Scand J Immunol; 1979; 9(2):135-40. PubMed ID: 424702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal glycoprotein activates the alternative complement pathway by reacting with factor H.
    Winsnes R; Lachmann PJ
    Scand J Immunol; 1982 Apr; 15(4):371-8. PubMed ID: 6213029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
    Sundsmo JS; Götze O
    J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.
    Olesen EH; Johnson AA; Damgaard G; Leslie RG
    Immunology; 1998 Feb; 93(2):177-83. PubMed ID: 9616366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A; Hieny S; Joiner K
    J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.
    Lambris J; Papamichail M; Ioannidis C; Dimitracopoulos G
    J Infect Dis; 1982 Jan; 145(1):78-82. PubMed ID: 6798132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.
    Matsumoto M; Yamashita F; Iida K; Tomita M; Seya T
    J Exp Med; 1995 Jan; 181(1):115-25. PubMed ID: 7806998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, partial characterisation and complement inhibiting activity of a new glycoprotein from Cuscuta europea.
    Zhelev ZD; Stanilova SA; Carpenter BG
    Biochem Biophys Res Commun; 1994 Jul; 202(1):186-94. PubMed ID: 8037713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a third component of complement-binding glycoprotein of human platelets.
    Yu GH; Holers VM; Seya T; Ballard L; Atkinson JP
    J Clin Invest; 1986 Aug; 78(2):494-501. PubMed ID: 2942562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragments.
    Sármay G; Ramos OF; Klein E; Kai C; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):969-74. PubMed ID: 3111862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate structures of the third component of rat complement. Presence of both high-mannose and complex type oligosaccharide chains.
    Miki K; Ogata S; Misumi Y; Ikehara Y
    Biochem J; 1986 Dec; 240(3):691-8. PubMed ID: 3827861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
    Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
    Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure.
    Crispin MD; Ritchie GE; Critchley AJ; Morgan BP; Wilson IA; Dwek RA; Sim RB; Rudd PM
    FEBS Lett; 2004 May; 566(1-3):270-4. PubMed ID: 15147907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN; Nilsson B
    J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1977 Jul; 146(1):257-70. PubMed ID: 301546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of activated properdin with complexes of properdin with C3.
    Whiteman LY; Purkall DB; Ruddy S
    J Immunol; 1991 Aug; 147(4):1344-51. PubMed ID: 1869827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 component of complement secreted by established cell lines.
    Senger DR; Hynes RO
    Cell; 1978 Oct; 15(2):375-84. PubMed ID: 569023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat intestinal glycoprotein lowering bactericidal activity of serum on 32P-labelled E. coli.
    Winsnes R; Midtvedt T; Trippestad A
    Acta Pathol Microbiol Scand C; 1976 Apr; 84(2):77-85. PubMed ID: 773105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.